ACYCLOVIR

ACYCLOVIR was reported 115339 times

ACYCLOVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SENSITISATION 159 0.2095
1 EJECTION FRACTION 117 0.2014
2 ENCEPHALITIS HERPES 92 0.1862
3 OPHTHALMIC HERPES SIMPLEX 81 0.1406
4 ENGRAFTMENT SYNDROME 77 0.1303
5 LIGHT CHAIN ANALYSIS INCREASED 128 0.1239
6 URINE LEUKOCYTE ESTERASE POSITIVE 79 0.1129
7 URINARY SEDIMENT PRESENT 66 0.1025
8 POLYCYSTIC OVARIES 159 0.1024
9 RED BLOOD CELLS URINE POSITIVE 97 0.1003
10 FUSARIUM INFECTION 69 0.0986
11 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 117 0.0828
12 PLASMACYTOMA 154 0.0827
13 PLASMA CELL MYELOMA RECURRENT 268 0.0824
14 MONOCLONAL IMMUNOGLOBULIN PRESENT 62 0.0816
15 VARICELLA ZOSTER VIRUS INFECTION 162 0.0781
16 ENCEPHALITIS VIRAL 93 0.0764
17 GRAFT VERSUS HOST DISEASE 548 0.0761
18 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 198 0.0716
19 ACUTE GRAFT VERSUS HOST DISEASE 320 0.0698
20 NEUTROPHIL PERCENTAGE INCREASED 87 0.0689
21 TOXOPLASMOSIS 73 0.0676
22 PLASMA CELL MYELOMA 2621 0.0671
23 LYMPHOCYTE PERCENTAGE DECREASED 90 0.0670
24 CYTOMEGALOVIRUS TEST POSITIVE 118 0.0661
25 ENTEROCOCCAL BACTERAEMIA 70 0.0660
26 GRAFT VERSUS HOST DISEASE IN SKIN 139 0.0630
27 EJECTION FRACTION ABNORMAL 76 0.0620
28 STEM CELL TRANSPLANT 155 0.0620
29 SYSTEMIC MYCOSIS 72 0.0616
30 PARAINFLUENZAE VIRUS INFECTION 93 0.0611
31 CYTOKINE RELEASE SYNDROME 1213 0.0604
32 PNEUMONIA CYTOMEGALOVIRAL 117 0.0602
33 PLASMA CELL MYELOMA REFRACTORY 77 0.0575
34 HERPES SIMPLEX 373 0.0573
35 CHRONIC GRAFT VERSUS HOST DISEASE 206 0.0570
36 CULTURE URINE POSITIVE 80 0.0569
37 WHITE BLOOD CELLS URINE POSITIVE 107 0.0568
38 ACUTE MYELOID LEUKAEMIA RECURRENT 119 0.0554
39 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 72 0.0547
40 FULL BLOOD COUNT DECREASED 1100 0.0545
41 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 115 0.0540
42 ASPERGILLOSIS 70 0.0536
43 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 317 0.0535
44 FULL BLOOD COUNT INCREASED 63 0.0529
45 NEPHRECTOMY 78 0.0525
46 CYTOMEGALOVIRUS INFECTION REACTIVATION 224 0.0507
47 SYSTEMIC CANDIDA 127 0.0505
48 CYTOMEGALOVIRUS VIRAEMIA 223 0.0501
49 PNEUMONIA FUNGAL 195 0.0494
50 HERPES OPHTHALMIC 65 0.0492
51 PSEUDOMONAL SEPSIS 84 0.0479
52 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 232 0.0455
53 OBSTRUCTIVE SLEEP APNOEA SYNDROME 66 0.0452
54 GENITAL HERPES 69 0.0451
55 MUCORMYCOSIS 117 0.0450
56 STENOTROPHOMONAS INFECTION 61 0.0450
57 HUMAN HERPESVIRUS 6 INFECTION 85 0.0449
58 EPSTEIN-BARR VIRUS INFECTION 280 0.0448
59 CYTOMEGALOVIRUS CHORIORETINITIS 87 0.0446
60 BACTERIAL SEPSIS 145 0.0445
61 RHINITIS ALLERGIC 198 0.0444
62 BONE MARROW TRANSPLANT 84 0.0443
63 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 114 0.0441
64 VENOOCCLUSIVE LIVER DISEASE 217 0.0439
65 HERPES VIRUS INFECTION 251 0.0435
66 POST HERPETIC NEURALGIA 62 0.0431
67 FEBRILE NEUTROPENIA 2834 0.0427
68 APLASTIC ANAEMIA 223 0.0427
69 CYTOMEGALOVIRUS INFECTION 702 0.0422
70 FUNGAEMIA 66 0.0419
71 CYSTITIS HAEMORRHAGIC 167 0.0414
72 LEUKAEMIA RECURRENT 70 0.0414
73 ESCHERICHIA BACTERAEMIA 97 0.0412
74 TOXIC ENCEPHALOPATHY 209 0.0412
75 ENTEROCOCCAL INFECTION 199 0.0411
76 NEUROTOXICITY 716 0.0408
77 NEUTROPHIL COUNT ABNORMAL 114 0.0403
78 BRONCHOPULMONARY ASPERGILLOSIS 311 0.0401
79 OSTEOLYSIS 81 0.0396
80 VENOOCCLUSIVE DISEASE 99 0.0395
81 MULTIPLE MYELOMA 184 0.0394
82 HYPOGAMMAGLOBULINAEMIA 258 0.0392
83 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 69 0.0390
84 ADENOVIRUS INFECTION 112 0.0386
85 BACTERIAL TEST POSITIVE 86 0.0385
86 URINE ABNORMALITY 175 0.0385
87 BONE LESION 135 0.0374
88 TUMOUR LYSIS SYNDROME 327 0.0371
89 URINE ANALYSIS ABNORMAL 111 0.0371
90 ENCEPHALITIS 254 0.0367
91 PNEUMONIA VIRAL 117 0.0367
92 STAPHYLOCOCCAL BACTERAEMIA 154 0.0354
93 CYTOPENIA 430 0.0351
94 NEUTROPENIC SEPSIS 238 0.0333
95 BLOOD IMMUNOGLOBULIN G DECREASED 81 0.0327
96 MUCOSAL INFLAMMATION 852 0.0325
97 ACUTE MYELOID LEUKAEMIA 506 0.0324
98 RHINOVIRUS INFECTION 126 0.0323
99 BACTERAEMIA 374 0.0315
100 NEUTROPHIL COUNT DECREASED 1273 0.0312
101 LYMPHOCYTE COUNT DECREASED 548 0.0310
102 COVID-19 PNEUMONIA 364 0.0308
103 CHRONIC LYMPHOCYTIC LEUKAEMIA 146 0.0307
104 CLOSTRIDIUM DIFFICILE COLITIS 326 0.0307
105 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 228 0.0304
106 BK VIRUS INFECTION 102 0.0302
107 ACUTE LYMPHOCYTIC LEUKAEMIA 85 0.0300
108 WHITE BLOOD CELL COUNT DECREASED 3223 0.0297
109 ESCHERICHIA SEPSIS 86 0.0296
110 NEUTROPENIC COLITIS 61 0.0295
111 PLATELET COUNT DECREASED 3097 0.0290
112 VARICELLA 68 0.0284
113 HYPERPARATHYROIDISM SECONDARY 71 0.0283
114 LABORATORY TEST ABNORMAL 821 0.0278
115 NEUROPATHY PERIPHERAL 2646 0.0278
116 STAPHYLOCOCCAL SEPSIS 137 0.0277
117 RED CELL DISTRIBUTION WIDTH INCREASED 115 0.0277
118 NEPHROGENIC ANAEMIA 128 0.0276
119 RESPIRATORY TRACT INFECTION VIRAL 64 0.0275
120 HOSPICE CARE 267 0.0270
121 PANCYTOPENIA 1499 0.0268
122 NEPHROPATHY TOXIC 298 0.0265
123 LACTOSE INTOLERANCE 66 0.0257
124 PROTEIN TOTAL INCREASED 68 0.0255
125 ENCEPHALOPATHY 624 0.0254
126 RESPIRATORY SYNCYTIAL VIRUS INFECTION 221 0.0254
127 MULTIPLE ORGAN DYSFUNCTION SYNDROME 718 0.0253
128 HISTIOCYTOSIS HAEMATOPHAGIC 75 0.0252
129 RED BLOOD CELL COUNT DECREASED 719 0.0251
130 WHITE BLOOD CELL DISORDER 67 0.0250
131 ASPERGILLUS INFECTION 161 0.0245
132 BLOOD TEST ABNORMAL 343 0.0244
133 BLOOD CULTURE POSITIVE 73 0.0244
134 HYPERBILIRUBINAEMIA 251 0.0242
135 FIBRIN D DIMER INCREASED 86 0.0242
136 KLEBSIELLA INFECTION 122 0.0241
137 NEUTROPENIA 3274 0.0241
138 PLEURITIC PAIN 65 0.0235
139 BONE MARROW DISORDER 71 0.0235
140 SEPTIC SHOCK 1019 0.0234
141 PROTEIN TOTAL DECREASED 88 0.0233
142 SQUAMOUS CELL CARCINOMA OF SKIN 140 0.0232
143 PATHOGEN RESISTANCE 211 0.0231
144 THROMBOTIC MICROANGIOPATHY 224 0.0230
145 RENAL TUBULAR DISORDER 64 0.0227
146 ATELECTASIS 218 0.0225
147 FULL BLOOD COUNT ABNORMAL 238 0.0225
148 HERPES ZOSTER 1284 0.0223
149 LUNG INFILTRATION 197 0.0223
150 TOXIC EPIDERMAL NECROLYSIS 337 0.0222
151 THROMBOCYTOPENIA 2480 0.0222
152 HYPERURICAEMIA 91 0.0221
153 DIFFUSE LARGE B-CELL LYMPHOMA 170 0.0220
154 PSEUDOMONAS INFECTION 188 0.0219
155 VITAMIN B12 DECREASED 63 0.0218
156 LYMPHOPENIA 307 0.0217
157 LUNG CONSOLIDATION 60 0.0214
158 PATHOLOGICAL FRACTURE 107 0.0211
159 PNEUMONIA BACTERIAL 191 0.0208
160 IMMUNE THROMBOCYTOPENIA 95 0.0207
161 BLOOD PHOSPHORUS DECREASED 75 0.0205
162 REBOUND ACID HYPERSECRETION 62 0.0205
163 PLATELET COUNT ABNORMAL 123 0.0203
164 HORDEOLUM 88 0.0203
165 HAEMATOTOXICITY 192 0.0202
166 IMMUNOSUPPRESSION 178 0.0202
167 MULTIPLE ALLERGIES 158 0.0201
168 SEPSIS 2248 0.0201
169 MULTIPLE-DRUG RESISTANCE 62 0.0200
170 RASH VESICULAR 96 0.0198
171 MENINGITIS ASEPTIC 89 0.0198
172 BLOOD CREATININE DECREASED 62 0.0198
173 ESCHERICHIA URINARY TRACT INFECTION 84 0.0197
174 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 75 0.0196
175 COMPRESSION FRACTURE 102 0.0190
176 HAEMATOCRIT DECREASED 376 0.0189
177 FAILURE TO THRIVE 98 0.0189
178 BLOOD UREA INCREASED 315 0.0188
179 SPLENOMEGALY 220 0.0188
180 SEASONAL ALLERGY 265 0.0187
181 ESCHERICHIA INFECTION 154 0.0187
182 MULTI-ORGAN FAILURE 323 0.0187
183 WHITE BLOOD CELL COUNT ABNORMAL 119 0.0186
184 PULMONARY THROMBOSIS 203 0.0186
185 APLASIA PURE RED CELL 64 0.0186
186 SERUM FERRITIN INCREASED 98 0.0186
187 HYPERCALCAEMIA 229 0.0185
188 TOOTH DISORDER 412 0.0185
189 RENAL FAILURE ACUTE 780 0.0184
190 AUTOIMMUNE HAEMOLYTIC ANAEMIA 63 0.0184
191 ORAL HERPES 358 0.0183
192 BLOOD BILIRUBIN INCREASED 490 0.0181
193 TRANSFUSION 190 0.0181
194 VASCULAR DEVICE INFECTION 82 0.0181
195 BLOOD ALBUMIN DECREASED 143 0.0180
196 LEUKAEMIA 169 0.0179
197 BLOOD LACTATE DEHYDROGENASE INCREASED 283 0.0178
198 DISSEMINATED INTRAVASCULAR COAGULATION 251 0.0178
199 ATRIAL FLUTTER 142 0.0178
200 CARPAL TUNNEL SYNDROME 248 0.0177
201 ENTEROCOLITIS 102 0.0177
202 PNEUMONIA 5695 0.0176
203 DRUG RESISTANCE 447 0.0174
204 HYPOALBUMINAEMIA 134 0.0172
205 PNEUMOCYSTIS JIROVECII PNEUMONIA 173 0.0172
206 CLOSTRIDIUM DIFFICILE INFECTION 376 0.0172
207 HYPOPHOSPHATAEMIA 127 0.0172
208 BLOOD CALCIUM DECREASED 193 0.0171
209 MYELODYSPLASTIC SYNDROME 248 0.0171
210 TASTE DISORDER 347 0.0171
211 HYPOXIA 600 0.0170
212 BLOOD POTASSIUM DECREASED 510 0.0169
213 MENINGITIS 113 0.0169
214 BLOOD CREATININE INCREASED 1098 0.0168
215 ACUTE RESPIRATORY FAILURE 323 0.0168
216 ACUTE KIDNEY INJURY 2563 0.0167
217 CANDIDA INFECTION 281 0.0166
218 HYPERVOLAEMIA 82 0.0166
219 HAEMODIALYSIS 139 0.0165
220 MONOCYTE COUNT INCREASED 60 0.0165
221 RENAL TUBULAR NECROSIS 162 0.0165
222 BACTERIAL INFECTION 307 0.0164
223 BLOOD MAGNESIUM DECREASED 142 0.0164
224 SPINAL COMPRESSION FRACTURE 136 0.0164
225 SPINAL OSTEOARTHRITIS 143 0.0163
226 IMMUNODEFICIENCY 242 0.0162
227 VIRAL UPPER RESPIRATORY TRACT INFECTION 77 0.0162
228 THROMBOSIS 1300 0.0161
229 HAEMOGLOBIN DECREASED 1649 0.0160
230 DEEP VEIN THROMBOSIS 1043 0.0160
231 ACUTE RESPIRATORY DISTRESS SYNDROME 283 0.0160
232 RASH MACULO-PAPULAR 353 0.0159
233 CATHETER SITE INFECTION 60 0.0158
234 HYPOKALAEMIA 730 0.0158
235 MENTAL STATUS CHANGES 438 0.0158
236 STATUS EPILEPTICUS 178 0.0157
237 CANDIDIASIS 63 0.0157
238 ORTHOSTATIC HYPOTENSION 273 0.0157
239 INCREASED TENDENCY TO BRUISE 144 0.0156
240 AGEUSIA 389 0.0156
241 BENIGN PROSTATIC HYPERPLASIA 80 0.0155
242 PERIPHERAL SENSORY NEUROPATHY 90 0.0154
243 BODY HEIGHT DECREASED 164 0.0153
244 FEBRILE BONE MARROW APLASIA 65 0.0153
245 STAPHYLOCOCCAL INFECTION 502 0.0152
246 PERFORMANCE STATUS DECREASED 71 0.0152
247 TRANSPLANT REJECTION 120 0.0150
248 BLOOD COUNT ABNORMAL 227 0.0150
249 HICCUPS 122 0.0148
250 PROTEIN URINE PRESENT 74 0.0148
251 RESPIRATORY FAILURE 1075 0.0147
252 MUSCULOSKELETAL CHEST PAIN 228 0.0147
253 RENAL DISORDER 682 0.0146
254 PULMONARY ALVEOLAR HAEMORRHAGE 82 0.0146
255 SKIN ABRASION 69 0.0146
256 BONE MARROW FAILURE 294 0.0145
257 ORAL DISORDER 106 0.0144
258 PYREXIA 4977 0.0144
259 BLOOD URIC ACID INCREASED 83 0.0144
260 LEFT VENTRICULAR HYPERTROPHY 61 0.0142
261 UPPER RESPIRATORY TRACT INFECTION 658 0.0142
262 PETECHIAE 148 0.0142
263 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 110 0.0141
264 HAEMOGLOBIN ABNORMAL 91 0.0141
265 PARTIAL SEIZURES 74 0.0141
266 DERMATITIS BULLOUS 102 0.0141
267 STREPTOCOCCAL INFECTION 78 0.0140
268 BLOOD CREATINE INCREASED 62 0.0140
269 ALTERED STATE OF CONSCIOUSNESS 302 0.0139
270 HYPERNATRAEMIA 69 0.0138
271 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 356 0.0138
272 CONSTIPATION 2978 0.0136
273 LEUKOPENIA 682 0.0136
274 ANAEMIA 2590 0.0136
275 PLEURAL EFFUSION 825 0.0135
276 SINUS TACHYCARDIA 192 0.0135
277 SLEEP APNOEA SYNDROME 257 0.0135
278 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 111 0.0134
279 NEPHROPATHY 125 0.0134
280 ATRIAL FIBRILLATION 1303 0.0134
281 GINGIVITIS 72 0.0133
282 RENAL FAILURE 1764 0.0133
283 OSTEOPENIA 201 0.0132
284 OLIGURIA 82 0.0132
285 BLOOD THYROID STIMULATING HORMONE DECREASED 60 0.0132
286 PULMONARY HAEMORRHAGE 103 0.0132
287 IMMUNE SYSTEM DISORDER 173 0.0131
288 LUMBAR VERTEBRAL FRACTURE 60 0.0131
289 ODYNOPHAGIA 78 0.0131
290 PERICARDIAL EFFUSION 302 0.0130
291 TACHYPNOEA 177 0.0130
292 INFUSION SITE EXTRAVASATION 81 0.0130
293 ECCHYMOSIS 89 0.0130
294 HEPATITIS B 78 0.0129
295 CELLULITIS 651 0.0129
296 RALES 75 0.0129
297 VITAMIN D DECREASED 110 0.0129
298 POLYNEUROPATHY 154 0.0128
299 C-REACTIVE PROTEIN INCREASED 466 0.0128
300 ASPARTATE AMINOTRANSFERASE INCREASED 680 0.0128
301 HYPOMAGNESAEMIA 176 0.0126
302 END STAGE RENAL DISEASE 229 0.0125
303 ALANINE AMINOTRANSFERASE INCREASED 770 0.0125
304 DEVICE RELATED INFECTION 193 0.0125
305 ORAL CANDIDIASIS 165 0.0125
306 SPINAL FRACTURE 251 0.0125
307 RENAL IMPAIRMENT 1050 0.0125
308 BLOOD ALKALINE PHOSPHATASE INCREASED 306 0.0123
309 STOMATITIS 747 0.0123
310 BLOOD URINE PRESENT 233 0.0123
311 SKIN LESION 335 0.0122
312 PAPULE 86 0.0122
313 HYDRONEPHROSIS 91 0.0121
314 URINE OUTPUT DECREASED 106 0.0121
315 SINUS BRADYCARDIA 117 0.0121
316 HYPOTHYROIDISM 386 0.0121
317 HYPERTRANSAMINASAEMIA 84 0.0121
318 FUNGAL INFECTION 402 0.0120
319 RESPIRATORY TRACT INFECTION 314 0.0120
320 GASTROINTESTINAL INFECTION 108 0.0120
321 NECROSIS 67 0.0120
322 BODY TEMPERATURE INCREASED 245 0.0120
323 BASAL CELL CARCINOMA 187 0.0120
324 TOOTH INFECTION 157 0.0119
325 LUNG INFECTION 185 0.0119
326 HAEMORRHAGE INTRACRANIAL 178 0.0119
327 MALNUTRITION 133 0.0119
328 DRUG LEVEL INCREASED 194 0.0117
329 GENERALISED OEDEMA 145 0.0117
330 RASH PRURITIC 633 0.0117
331 BLOOD SODIUM DECREASED 220 0.0117
332 CHRONIC KIDNEY DISEASE 886 0.0116
333 SUBDURAL HAEMATOMA 166 0.0116
334 INFECTION 1675 0.0116
335 PNEUMONITIS 315 0.0116
336 DIARRHOEA 7417 0.0115
337 LYMPHADENOPATHY 405 0.0114
338 PULMONARY OEDEMA 511 0.0114
339 HEPATIC CYTOLYSIS 145 0.0114
340 SINUS DISORDER 225 0.0113
341 RESPIRATORY DISTRESS 312 0.0113
342 ENTERITIS 72 0.0112
343 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 191 0.0112
344 HEPATOMEGALY 110 0.0112
345 VIRAL INFECTION 371 0.0111
346 ACIDOSIS 85 0.0111
347 RIB FRACTURE 228 0.0111
348 BLOOD CALCIUM INCREASED 97 0.0110
349 ANURIA 95 0.0110
350 STEVENS-JOHNSON SYNDROME 245 0.0110
351 BACK DISORDER 179 0.0110
352 DIVERTICULITIS 304 0.0110
353 CARDIAC FAILURE ACUTE 73 0.0109
354 PULMONARY MASS 163 0.0109
355 GAMMA-GLUTAMYLTRANSFERASE INCREASED 242 0.0109
356 INTERVERTEBRAL DISC DEGENERATION 101 0.0109
357 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 104 0.0109
358 HYPOCALCAEMIA 206 0.0109
359 DISEASE PROGRESSION 1287 0.0109
360 GOUT 195 0.0109
361 BRAIN OEDEMA 137 0.0108
362 TRICUSPID VALVE INCOMPETENCE 86 0.0108
363 HEPATOTOXICITY 241 0.0108
364 DEHYDRATION 1443 0.0108
365 ONYCHOCLASIS 74 0.0107
366 HAEMOLYSIS 83 0.0107
367 CORONAVIRUS INFECTION 71 0.0107
368 EYE INFECTION 121 0.0107
369 WHITE BLOOD CELL COUNT INCREASED 410 0.0107
370 LEUKOCYTOSIS 193 0.0107
371 HYPOPHAGIA 272 0.0106
372 SPINAL DISORDER 100 0.0105
373 COVID-19 1846 0.0105
374 MITRAL VALVE INCOMPETENCE 119 0.0105
375 SUPRAVENTRICULAR TACHYCARDIA 100 0.0104
376 GINGIVAL PAIN 83 0.0104
377 ELECTROLYTE IMBALANCE 121 0.0104
378 FATIGUE 8096 0.0104
379 TUBULOINTERSTITIAL NEPHRITIS 194 0.0103
380 BRONCHITIS 766 0.0103
381 TRANSAMINASES INCREASED 230 0.0103
382 TOOTH ABSCESS 105 0.0103
383 DECUBITUS ULCER 84 0.0103
384 PERIPHERAL SWELLING 1586 0.0103
385 PURPURA 91 0.0103
386 INFLUENZA 1146 0.0103
387 SINUSITIS 1053 0.0103
388 PULMONARY EMBOLISM 976 0.0103
389 PROCTALGIA 66 0.0103
390 BONE DISORDER 187 0.0103
391 BONE PAIN 597 0.0102
392 UROSEPSIS 94 0.0102
393 INFUSION SITE SWELLING 64 0.0102
394 OSTEOMYELITIS 184 0.0102
395 NEURALGIA 247 0.0101
396 HEPATITIS ACUTE 66 0.0101
397 RENAL FAILURE CHRONIC 78 0.0101
398 MUSCLE SPASMS 1860 0.0101
399 HYPERLIPIDAEMIA 121 0.0101
400 HYPERGLYCAEMIA 366 0.0100
401 CATARACT 598 0.0100
402 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 103 0.0100
403 ORAL PAIN 223 0.0099
404 SARS-COV-2 TEST POSITIVE 131 0.0099
405 DECREASED APPETITE 2301 0.0099
406 MYOCLONUS 118 0.0099
407 TENDERNESS 103 0.0099
408 RASH 4308 0.0099
409 ATAXIA 117 0.0098
410 CARDIOMEGALY 121 0.0098
411 LARGE INTESTINE POLYP 68 0.0098
412 COLITIS 372 0.0098
413 OESOPHAGITIS 107 0.0098
414 AGRANULOCYTOSIS 182 0.0098
415 URINARY TRACT INFECTION 1668 0.0098
416 BRAIN FOG 152 0.0097
417 NEUTROPHIL COUNT INCREASED 99 0.0097
418 SMALL INTESTINAL OBSTRUCTION 119 0.0097
419 ILEUS 120 0.0096
420 OEDEMA 522 0.0096
421 HAEMOLYTIC ANAEMIA 86 0.0096
422 DIZZINESS POSTURAL 93 0.0096
423 HAEMODYNAMIC INSTABILITY 73 0.0096
424 RENAL CYST 76 0.0096
425 ASCITES 281 0.0095
426 THERAPY PARTIAL RESPONDER 149 0.0095
427 DRUG TOXICITY 130 0.0095
428 HEPATIC FAILURE 287 0.0095
429 CONFUSIONAL STATE 1536 0.0095
430 FACIAL PARALYSIS 81 0.0095
431 HYPONATRAEMIA 533 0.0095
432 GASTROENTERITIS 138 0.0094
433 NERVOUS SYSTEM DISORDER 295 0.0094
434 SKIN INFECTION 106 0.0094
435 VITAMIN D DEFICIENCY 92 0.0094
436 LOCALISED INFECTION 228 0.0094
437 MOUTH HAEMORRHAGE 69 0.0094
438 LEFT VENTRICULAR DYSFUNCTION 63 0.0094
439 TOXIC SKIN ERUPTION 94 0.0093
440 OEDEMA PERIPHERAL 1134 0.0093
441 HYPOTENSION 1864 0.0093
442 DIVERTICULUM 66 0.0093
443 HAEMOPTYSIS 259 0.0093
444 PRODUCT DISTRIBUTION ISSUE 86 0.0093
445 GASTROOESOPHAGEAL REFLUX DISEASE 744 0.0092
446 CHILLS 1081 0.0092
447 APHASIA 278 0.0092
448 FACIAL PAIN 82 0.0092
449 EMBOLISM 76 0.0091
450 DEPRESSED LEVEL OF CONSCIOUSNESS 362 0.0091
451 DRUG ERUPTION 162 0.0091
452 SECOND PRIMARY MALIGNANCY 76 0.0091
453 GALLBLADDER DISORDER 163 0.0091
454 NIGHT SWEATS 294 0.0091
455 PROTEINURIA 173 0.0091
456 LIVER FUNCTION TEST ABNORMAL 264 0.0091
457 DELIRIUM 315 0.0091
458 CHOLESTASIS 174 0.0091
459 PHARYNGITIS 112 0.0090
460 VASCULITIS 105 0.0090
461 PHOTOPHOBIA 169 0.0090
462 DERMATITIS ALLERGIC 113 0.0090
463 DENTAL CARIES 99 0.0089
464 ANHEDONIA 235 0.0089
465 RESPIRATORY TRACT CONGESTION 142 0.0089
466 ASTHENIA 3360 0.0089
467 NEPHROTIC SYNDROME 61 0.0089
468 WEIGHT FLUCTUATION 93 0.0089
469 COAGULOPATHY 148 0.0089
470 UPPER-AIRWAY COUGH SYNDROME 73 0.0089
471 SCAB 101 0.0088
472 HAEMORRHOIDS 172 0.0088
473 CHOLECYSTITIS 105 0.0088
474 HYPOAESTHESIA 1319 0.0088
475 FIBROMYALGIA 214 0.0088
476 FLUID OVERLOAD 128 0.0088
477 LARGE INTESTINE PERFORATION 61 0.0088
478 SKIN DISCOLOURATION 402 0.0087
479 BLOOD POTASSIUM INCREASED 142 0.0087
480 DISORIENTATION 346 0.0087
481 MASS 122 0.0087
482 GINGIVAL BLEEDING 119 0.0087
483 ERYTHEMA MULTIFORME 81 0.0087
484 TOOTHACHE 157 0.0087
485 HALLUCINATION, VISUAL 183 0.0087
486 EOSINOPHIL COUNT INCREASED 72 0.0086
487 MOUTH ULCERATION 182 0.0086
488 LIPASE INCREASED 66 0.0086
489 FLUID RETENTION 438 0.0086
490 LYMPHOMA 133 0.0086
491 SQUAMOUS CELL CARCINOMA 81 0.0086
492 DERMATITIS CONTACT 98 0.0086
493 DYSPNOEA EXERTIONAL 323 0.0086
494 PERIPHERAL COLDNESS 117 0.0085
495 ARTHROPOD BITE 63 0.0085
496 VENTRICULAR EXTRASYSTOLES 88 0.0085
497 LIVER DISORDER 375 0.0084
498 PRODUCT ADMINISTRATION INTERRUPTED 66 0.0084
499 ADVERSE DRUG REACTION 755 0.0084
500 NERVE INJURY 93 0.0084
501 SPINAL PAIN 98 0.0084
502 EPISTAXIS 625 0.0083
503 FURUNCLE 66 0.0083
504 MUSCLE STRAIN 72 0.0083
505 FLANK PAIN 78 0.0083
506 HYPOAESTHESIA ORAL 125 0.0083
507 SKIN LACERATION 90 0.0083
508 LIMB DISCOMFORT 256 0.0083
509 RASH GENERALISED 214 0.0083
510 NASOPHARYNGITIS 1518 0.0082
511 HAEMATURIA 282 0.0082
512 MYOPATHY 71 0.0082
513 HIP FRACTURE 264 0.0082
514 BLOOD IRON DECREASED 97 0.0082
515 TACHYCARDIA 725 0.0082
516 TORSADE DE POINTES 64 0.0081
517 DIARRHOEA HAEMORRHAGIC 76 0.0081
518 APHTHOUS ULCER 63 0.0081
519 ECONOMIC PROBLEM 123 0.0081
520 CYSTITIS 258 0.0081
521 CONJUNCTIVITIS 150 0.0081
522 OSTEONECROSIS OF JAW 200 0.0081
523 BACK PAIN 1877 0.0081
524 NOCTURIA 98 0.0081
525 INFUSION SITE PAIN 104 0.0081
526 GLOMERULAR FILTRATION RATE DECREASED 99 0.0080
527 UNEVALUABLE EVENT 609 0.0080
528 GENERALISED TONIC-CLONIC SEIZURE 133 0.0080
529 GASTROENTERITIS VIRAL 145 0.0080
530 DYSARTHRIA 302 0.0080
531 GASTRITIS 211 0.0080
532 EXOSTOSIS 73 0.0080
533 ARTERIOSCLEROSIS 75 0.0080
534 HEPATIC FUNCTION ABNORMAL 297 0.0079
535 CONTUSION 766 0.0079
536 LIVER FUNCTION TEST INCREASED 170 0.0079
537 RASH MACULAR 276 0.0079
538 EAR DISCOMFORT 81 0.0079
539 CHROMATURIA 178 0.0079
540 PNEUMOTHORAX 125 0.0079
541 BLOOD DISORDER 63 0.0079
542 SKIN CANCER 169 0.0078
543 HYPERKALAEMIA 274 0.0078
544 FEELING COLD 217 0.0078
545 NO THERAPEUTIC RESPONSE 95 0.0078
546 ROTATOR CUFF SYNDROME 100 0.0078
547 RASH PAPULAR 174 0.0078
548 SUBARACHNOID HAEMORRHAGE 79 0.0077
549 SKIN DISORDER 258 0.0077
550 THERAPY NON-RESPONDER 346 0.0077
551 PNEUMONIA ASPIRATION 192 0.0077
552 ACUTE HEPATIC FAILURE 105 0.0077
553 EYE PAIN 433 0.0077
554 DRY EYE 383 0.0077
555 PULMONARY CONGESTION 101 0.0077
556 PAIN IN JAW 216 0.0076
557 SKIN ULCER 197 0.0076
558 TOOTH FRACTURE 84 0.0076
559 BRADYCARDIA 404 0.0076
560 BALANCE DISORDER 657 0.0076
561 CENTRAL NERVOUS SYSTEM LESION 104 0.0076
562 RESPIRATORY DISORDER 226 0.0075
563 LIMB INJURY 205 0.0075
564 EJECTION FRACTION DECREASED 117 0.0075
565 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 361 0.0075
566 PRODUCTIVE COUGH 358 0.0075
567 COGNITIVE DISORDER 350 0.0075
568 RHINORRHOEA 484 0.0075
569 RHINITIS 60 0.0074
570 COUGH 2082 0.0074
571 MUSCULAR WEAKNESS 843 0.0074
572 OROPHARYNGEAL PAIN 685 0.0074
573 WOUND INFECTION 81 0.0074
574 APPENDICITIS 69 0.0074
575 GRAND MAL CONVULSION 68 0.0074
576 INFUSION RELATED REACTION 487 0.0073
577 SWELLING FACE 477 0.0073
578 LOWER RESPIRATORY TRACT INFECTION 333 0.0073
579 CEREBRAL HAEMORRHAGE 262 0.0073
580 OFF LABEL USE 6407 0.0073
581 EYE DISCHARGE 76 0.0073
582 TREMOR 1213 0.0073
583 SYNCOPE 731 0.0073
584 CARDIAC DISORDER 682 0.0073
585 CARDIAC MURMUR 63 0.0073
586 BLOOD THYROID STIMULATING HORMONE INCREASED 67 0.0073
587 IRON DEFICIENCY ANAEMIA 67 0.0073
588 RENAL INJURY 215 0.0072
589 DYSURIA 266 0.0072
590 EAR PAIN 140 0.0072
591 SINUS CONGESTION 97 0.0072
592 DYSGEUSIA 532 0.0072
593 BLADDER DISORDER 71 0.0071
594 VENTRICULAR TACHYCARDIA 118 0.0071
595 BLOOD PRESSURE ABNORMAL 142 0.0071
596 NAUSEA 5652 0.0071
597 HEPATIC STEATOSIS 133 0.0071
598 BLISTER 401 0.0071
599 POLLAKIURIA 297 0.0071
600 HEART RATE DECREASED 250 0.0071
601 EAR INFECTION 189 0.0071
602 HYPERSOMNIA 203 0.0071
603 OSTEOPOROSIS 291 0.0071
604 PLATELET COUNT INCREASED 92 0.0070
605 DIALYSIS 100 0.0070
606 HEPATIC ENZYME INCREASED 479 0.0070
607 EOSINOPHILIA 123 0.0070
608 FOOT FRACTURE 133 0.0070
609 INTERVERTEBRAL DISC PROTRUSION 153 0.0070
610 ARTHROPATHY 389 0.0070
611 SCIATICA 111 0.0070
612 NECK PAIN 389 0.0070
613 PARAESTHESIA 1093 0.0069
614 DECREASED IMMUNE RESPONSIVENESS 68 0.0069
615 FALL 2306 0.0069
616 PYELONEPHRITIS 60 0.0069
617 HEPATITIS 177 0.0069
618 LETHARGY 397 0.0069
619 RASH ERYTHEMATOUS 329 0.0069
620 LIGAMENT SPRAIN 68 0.0069
621 TRANSIENT ISCHAEMIC ATTACK 230 0.0068
622 CARDIAC FAILURE 546 0.0068
623 FACE OEDEMA 114 0.0068
624 HYPERCHOLESTEROLAEMIA 65 0.0067
625 URINARY RETENTION 224 0.0067
626 FEEDING DISORDER 136 0.0067
627 NEOPLASM 77 0.0067
628 LACERATION 63 0.0067
629 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 347 0.0066
630 NERVE COMPRESSION 61 0.0066
631 NEPHROLITHIASIS 303 0.0066
632 INTESTINAL PERFORATION 74 0.0066
633 OCULAR DISCOMFORT 74 0.0066
634 GASTRIC DISORDER 226 0.0066
635 DRUG LEVEL DECREASED 67 0.0066
636 WEIGHT DECREASED 1834 0.0066
637 CARDIAC FAILURE CONGESTIVE 527 0.0066
638 THYROID DISORDER 101 0.0065
639 POOR QUALITY SLEEP 141 0.0065
640 EYE SWELLING 243 0.0065
641 ANOREXIA 84 0.0065
642 MUSCULOSKELETAL DISORDER 124 0.0065
643 ABDOMINAL DISTENSION 677 0.0065
644 DIPLOPIA 168 0.0065
645 HEART RATE IRREGULAR 146 0.0065
646 URINARY INCONTINENCE 191 0.0064
647 BURNING SENSATION 452 0.0064
648 ADRENAL INSUFFICIENCY 78 0.0064
649 OSTEOARTHRITIS 272 0.0064
650 HERNIA 124 0.0064
651 DECREASED ACTIVITY 69 0.0064
652 UNRESPONSIVE TO STIMULI 165 0.0064
653 JAUNDICE 172 0.0064
654 PULMONARY HYPERTENSION 133 0.0064
655 POOR VENOUS ACCESS 66 0.0064
656 UPPER LIMB FRACTURE 127 0.0064
657 DYSPNOEA 3608 0.0064
658 DISEASE RECURRENCE 303 0.0064
659 CYST 79 0.0064
660 PRODUCT DOSE OMISSION 415 0.0064
661 INSOMNIA 1691 0.0063
662 SHOCK 146 0.0063
663 DYSPHAGIA 602 0.0063
664 EATING DISORDER 135 0.0063
665 INCONTINENCE 67 0.0063
666 PANCREATITIS ACUTE 142 0.0063
667 PRESYNCOPE 153 0.0063
668 CARDIOMYOPATHY 93 0.0063
669 HAEMATOMA 163 0.0063
670 HYPERTENSION 1332 0.0063
671 OXYGEN SATURATION DECREASED 352 0.0063
672 HEMIPARESIS 106 0.0063
673 VOMITING 2937 0.0062
674 GASTROINTESTINAL DISORDER 558 0.0062
675 SWELLING 580 0.0062
676 CHOLELITHIASIS 203 0.0062
677 DRUG-INDUCED LIVER INJURY 194 0.0062
678 DYSPEPSIA 608 0.0062
679 LUNG DISORDER 302 0.0062
680 CHEST DISCOMFORT 631 0.0062
681 DYSPHONIA 360 0.0061
682 WHEEZING 365 0.0061
683 EMPHYSEMA 62 0.0061
684 ANKLE FRACTURE 95 0.0061
685 BLOOD TRIGLYCERIDES INCREASED 108 0.0061
686 VISION BLURRED 837 0.0061
687 APHONIA 85 0.0061
688 ABDOMINAL PAIN 1414 0.0061
689 CORONARY ARTERY DISEASE 184 0.0061
690 ABDOMINAL DISCOMFORT 1013 0.0060
691 METABOLIC ACIDOSIS 193 0.0060
692 DEAFNESS 157 0.0060
693 GENERAL PHYSICAL HEALTH DETERIORATION 694 0.0060
694 LACRIMATION INCREASED 181 0.0060
695 MOTOR DYSFUNCTION 61 0.0060
696 CHEST PAIN 1107 0.0060
697 PARAESTHESIA ORAL 86 0.0060
698 ABSCESS 95 0.0059
699 UPPER GASTROINTESTINAL HAEMORRHAGE 100 0.0059
700 MYOCARDITIS 68 0.0059
701 THERAPY INTERRUPTED 423 0.0059
702 AMNESIA 385 0.0059
703 HAEMATEMESIS 150 0.0059
704 FLATULENCE 334 0.0059
705 EYE DISORDER 193 0.0059
706 GLAUCOMA 113 0.0059
707 BURSITIS 71 0.0058
708 GASTRIC ULCER 111 0.0058
709 FAECES DISCOLOURED 126 0.0058
710 KIDNEY INFECTION 114 0.0058
711 CARDIAC ARREST 479 0.0058
712 INTERSTITIAL LUNG DISEASE 280 0.0058
713 DIZZINESS 2873 0.0058
714 DYSSTASIA 168 0.0057
715 MALIGNANT MELANOMA 77 0.0057
716 AGITATION 422 0.0057
717 DRUG INTOLERANCE 555 0.0057
718 MUSCLE TIGHTNESS 93 0.0057
719 COORDINATION ABNORMAL 80 0.0057
720 DEATH 4923 0.0057
721 VERTIGO 348 0.0057
722 PRODUCT DOSE OMISSION ISSUE 1676 0.0057
723 PRURITUS 2187 0.0057
724 MICTURITION URGENCY 65 0.0057
725 ILLNESS 583 0.0057
726 DRY MOUTH 458 0.0056
727 FEELING JITTERY 107 0.0056
728 MUSCLE ATROPHY 71 0.0056
729 JOINT SWELLING 676 0.0056
730 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 307 0.0056
731 SPEECH DISORDER 293 0.0056
732 WOUND 156 0.0056
733 RESTLESSNESS 204 0.0056
734 OSTEONECROSIS 183 0.0056
735 SKIN EXFOLIATION 469 0.0056
736 ABDOMINAL PAIN UPPER 1144 0.0056
737 DRUG INTERACTION 880 0.0055
738 HALLUCINATION 418 0.0055
739 SENSORY DISTURBANCE 89 0.0055
740 EYE HAEMORRHAGE 74 0.0055
741 MACULAR DEGENERATION 66 0.0055
742 MEMORY IMPAIRMENT 759 0.0055
743 SCAR 94 0.0055
744 BRONCHOSPASM 78 0.0055
745 NEOPLASM PROGRESSION 190 0.0055
746 RESTLESS LEGS SYNDROME 99 0.0054
747 HEAD INJURY 172 0.0054
748 GAIT DISTURBANCE 1036 0.0054
749 HIATUS HERNIA 70 0.0054
750 ELECTROCARDIOGRAM QT PROLONGED 194 0.0054
751 IMPAIRED HEALING 177 0.0054
752 TINNITUS 247 0.0054
753 QUALITY OF LIFE DECREASED 72 0.0054
754 PSYCHOMOTOR HYPERACTIVITY 89 0.0054
755 NASAL CONGESTION 313 0.0053
756 ANOSMIA 77 0.0053
757 HEART RATE INCREASED 527 0.0053
758 JOINT RANGE OF MOTION DECREASED 71 0.0053
759 HEADACHE 3298 0.0053
760 HOSPITALISATION 806 0.0052
761 PARALYSIS 75 0.0052
762 FEELING HOT 321 0.0052
763 MUSCULOSKELETAL DISCOMFORT 90 0.0052
764 COMA 248 0.0052
765 PHOTOSENSITIVITY REACTION 86 0.0052
766 DRY SKIN 693 0.0052
767 INSURANCE ISSUE 79 0.0052
768 BLOOD PRESSURE DECREASED 342 0.0051
769 GAIT INABILITY 172 0.0051
770 MYELOSUPPRESSION 185 0.0051
771 BONE DENSITY DECREASED 160 0.0051
772 GASTROINTESTINAL HAEMORRHAGE 426 0.0051
773 SOMNOLENCE 1026 0.0051
774 MELAENA 112 0.0051
775 CONVULSION 291 0.0051
776 INCREASED APPETITE 97 0.0051
777 HAEMATOCHEZIA 280 0.0051
778 ARRHYTHMIA 240 0.0051
779 CONDITION AGGRAVATED 1540 0.0051
780 ABDOMINAL PAIN LOWER 128 0.0051
781 PAIN IN EXTREMITY 1491 0.0051
782 ACUTE MYOCARDIAL INFARCTION 149 0.0050
783 SKIN REACTION 71 0.0050
784 CEREBRAL INFARCTION 123 0.0050
785 URTICARIA 843 0.0050
786 LOSS OF CONSCIOUSNESS 643 0.0050
787 FEMUR FRACTURE 155 0.0050
788 PRODUCT DOSE OMISSION IN ERROR 141 0.0050
789 HEAD DISCOMFORT 88 0.0050
790 MYALGIA 845 0.0050
791 LIP SWELLING 165 0.0049
792 CARDIO-RESPIRATORY ARREST 207 0.0049
793 MULTIPLE FRACTURES 81 0.0049
794 WEIGHT INCREASED 1101 0.0049
795 BLOOD CHOLESTEROL INCREASED 229 0.0049
796 BLOOD PRESSURE INCREASED 747 0.0049
797 INTENTIONAL PRODUCT USE ISSUE 427 0.0049
798 MENTAL IMPAIRMENT 118 0.0049
799 HAIR TEXTURE ABNORMAL 65 0.0049
800 BLOOD PRESSURE SYSTOLIC INCREASED 94 0.0048
801 SEIZURE 556 0.0048
802 INTERNATIONAL NORMALISED RATIO INCREASED 137 0.0048
803 ERYTHEMA 984 0.0048
804 MUSCULOSKELETAL PAIN 250 0.0048
805 MALAISE 2090 0.0048
806 RECTAL HAEMORRHAGE 204 0.0047
807 DERMATITIS 99 0.0047
808 SKIN HAEMORRHAGE 70 0.0047
809 INTESTINAL OBSTRUCTION 178 0.0047
810 FEELING ABNORMAL 1131 0.0047
811 PAIN 2897 0.0047
812 ULCER 75 0.0047
813 INFLAMMATION 242 0.0047
814 ANXIETY 1320 0.0046
815 PRODUCT PRESCRIBING ISSUE 101 0.0046
816 PRODUCT USE IN UNAPPROVED INDICATION 1147 0.0046
817 BLOOD CREATINE PHOSPHOKINASE INCREASED 133 0.0046
818 IRRITABLE BOWEL SYNDROME 99 0.0046
819 ARTHRITIS 361 0.0046
820 CIRCULATORY COLLAPSE 78 0.0046
821 HYPERHIDROSIS 587 0.0046
822 ARTHRALGIA 1890 0.0045
823 MALIGNANT NEOPLASM PROGRESSION 464 0.0045
824 CARDIOGENIC SHOCK 65 0.0045
825 EPILEPSY 138 0.0045
826 DIABETES MELLITUS 344 0.0045
827 THROAT IRRITATION 201 0.0045
828 JOINT INJURY 95 0.0044
829 OCULAR HYPERAEMIA 211 0.0044
830 ERUCTATION 86 0.0044
831 DELUSION 69 0.0044
832 PANCREATITIS 234 0.0044
833 ISCHAEMIC STROKE 79 0.0044
834 NERVOUSNESS 231 0.0044
835 ADVERSE EVENT 407 0.0044
836 SLEEP DISORDER 311 0.0044
837 INTENTIONAL DOSE OMISSION 125 0.0044
838 PERICARDITIS 73 0.0043
839 FLUSHING 441 0.0043
840 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 101 0.0043
841 DEMENTIA 121 0.0043
842 SNEEZING 97 0.0043
843 DEPRESSION 983 0.0043
844 MUSCULOSKELETAL STIFFNESS 378 0.0043
845 LOCAL SWELLING 75 0.0043
846 PALLOR 117 0.0043
847 HYPOACUSIS 185 0.0043
848 COLON CANCER 64 0.0043
849 RETCHING 91 0.0043
850 EYE IRRITATION 245 0.0043
851 COLD SWEAT 75 0.0043
852 IMPAIRED QUALITY OF LIFE 61 0.0042
853 HOT FLUSH 317 0.0042
854 THIRST 75 0.0042
855 HAEMORRHAGE 437 0.0042
856 CEREBROVASCULAR ACCIDENT 708 0.0042
857 RHABDOMYOLYSIS 174 0.0042
858 BLOOD PRESSURE FLUCTUATION 100 0.0042
859 HALLUCINATION, AUDITORY 66 0.0041
860 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 295 0.0041
861 TENDONITIS 64 0.0041
862 PRODUCT USE COMPLAINT 65 0.0041
863 PULMONARY FIBROSIS 79 0.0041
864 BLOOD GLUCOSE ABNORMAL 76 0.0041
865 VISUAL IMPAIRMENT 506 0.0041
866 JOINT STIFFNESS 107 0.0041
867 LOWER LIMB FRACTURE 78 0.0041
868 PALPITATIONS 474 0.0040
869 MUSCLE TWITCHING 93 0.0040
870 MOOD ALTERED 109 0.0040
871 ASTHMA 451 0.0040
872 BLINDNESS 162 0.0040
873 TREATMENT NONCOMPLIANCE 216 0.0039
874 SWOLLEN TONGUE 123 0.0039
875 PRURITUS GENERALISED 85 0.0039
876 DISTURBANCE IN ATTENTION 211 0.0039
877 TOOTH LOSS 81 0.0039
878 DYSKINESIA 158 0.0039
879 FREQUENT BOWEL MOVEMENTS 105 0.0039
880 ABASIA 96 0.0039
881 PRODUCT AVAILABILITY ISSUE 88 0.0039
882 ALOPECIA 755 0.0038
883 HYPERSENSITIVITY 713 0.0038
884 ANGINA PECTORIS 110 0.0038
885 PRODUCT USE ISSUE 721 0.0038
886 PRESCRIBED UNDERDOSE 76 0.0038
887 POST PROCEDURAL COMPLICATION 73 0.0038
888 INFLUENZA LIKE ILLNESS 310 0.0038
889 THROAT TIGHTNESS 101 0.0037
890 METASTASES TO BONE 61 0.0037
891 LIVER INJURY 91 0.0037
892 GLOSSODYNIA 83 0.0037
893 VISUAL ACUITY REDUCED 122 0.0037
894 MOBILITY DECREASED 263 0.0037
895 FRACTURE 69 0.0036
896 SEROTONIN SYNDROME 70 0.0036
897 DRUG INEFFECTIVE 4759 0.0036
898 THINKING ABNORMAL 67 0.0036
899 MIDDLE INSOMNIA 67 0.0036
900 ABNORMAL BEHAVIOUR 142 0.0036
901 MULTIPLE SCLEROSIS RELAPSE 242 0.0035
902 THERAPY CESSATION 180 0.0035
903 SKIN FISSURES 68 0.0035
904 EYE PRURITUS 116 0.0034
905 PERITONITIS 71 0.0034
906 MIGRAINE 327 0.0034
907 PAIN OF SKIN 92 0.0034
908 NEOPLASM MALIGNANT 228 0.0034
909 ANGIOEDEMA 151 0.0034
910 ERECTILE DYSFUNCTION 87 0.0034
911 INJURY 238 0.0034
912 LACTIC ACIDOSIS 109 0.0034
913 ILL-DEFINED DISORDER 204 0.0034
914 ROAD TRAFFIC ACCIDENT 140 0.0033
915 SURGERY 196 0.0033
916 DRUG DOSE OMISSION 547 0.0033
917 PSYCHOTIC DISORDER 97 0.0033
918 PANIC ATTACK 117 0.0032
919 HEPATIC CIRRHOSIS 60 0.0032
920 DISCOMFORT 193 0.0032
921 PRESCRIBED OVERDOSE 61 0.0031
922 CARDIOVASCULAR DISORDER 80 0.0031
923 TREATMENT FAILURE 261 0.0031
924 EMOTIONAL DISORDER 97 0.0031
925 IRRITABILITY 189 0.0031
926 PHARMACEUTICAL PRODUCT COMPLAINT 81 0.0031
927 EMOTIONAL DISTRESS 370 0.0031
928 TOXICITY TO VARIOUS AGENTS 514 0.0030
929 MOOD SWINGS 97 0.0030
930 MENTAL DISORDER 132 0.0030
931 MYOCARDIAL INFARCTION 521 0.0030
932 PRODUCT PRESCRIBING ERROR 71 0.0030
933 PRODUCT PHYSICAL ISSUE 60 0.0030
934 TYPE 2 DIABETES MELLITUS 100 0.0030
935 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 534 0.0030
936 MOVEMENT DISORDER 95 0.0030
937 ACCIDENTAL OVERDOSE 106 0.0029
938 DEPRESSED MOOD 152 0.0029
939 MULTIPLE SCLEROSIS 137 0.0029
940 ANAPHYLACTIC REACTION 158 0.0029
941 THERAPEUTIC RESPONSE UNEXPECTED 128 0.0029
942 DRUG EXPOSURE DURING PREGNANCY 97 0.0028
943 PROCEDURAL PAIN 77 0.0028
944 AGGRESSION 138 0.0028
945 ECZEMA 143 0.0027
946 BLOOD GLUCOSE INCREASED 503 0.0027
947 THERAPEUTIC RESPONSE DECREASED 161 0.0027
948 THERAPEUTIC PRODUCT EFFECT DECREASED 116 0.0026
949 PREMATURE BABY 77 0.0026
950 RESPIRATORY ARREST 70 0.0025
951 HYPOGLYCAEMIA 123 0.0025
952 NIGHTMARE 87 0.0025
953 MEDICATION ERROR 138 0.0025
954 CRYING 90 0.0025
955 EXPOSURE DURING PREGNANCY 150 0.0024
956 ABNORMAL DREAMS 66 0.0024
957 DRUG ADMINISTRATION ERROR 72 0.0023
958 VAGINAL HAEMORRHAGE 94 0.0022
959 SYSTEMIC LUPUS ERYTHEMATOSUS 76 0.0021
960 FOETAL EXPOSURE DURING PREGNANCY 173 0.0021
961 MATERNAL EXPOSURE DURING PREGNANCY 189 0.0021
962 ACNE 157 0.0021
963 SUICIDAL IDEATION 188 0.0021
964 BLOOD GLUCOSE DECREASED 95 0.0020
965 COLITIS ULCERATIVE 86 0.0019
966 ANGER 65 0.0019
967 INCORRECT DOSE ADMINISTERED 436 0.0019
968 LUNG NEOPLASM MALIGNANT 77 0.0019
969 SKIN IRRITATION 81 0.0018
970 DRUG EFFECT DECREASED 93 0.0017
971 PRODUCT SUBSTITUTION ISSUE 99 0.0017
972 SKIN BURNING SENSATION 116 0.0016
973 ABORTION SPONTANEOUS 61 0.0015
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 107 0.0015
975 OVERDOSE 318 0.0015
976 INJECTION SITE REACTION 100 0.0015
977 PRODUCT QUALITY ISSUE 196 0.0014
978 INJECTION SITE PRURITUS 96 0.0014
979 DERMATITIS ATOPIC 74 0.0014
980 INTENTIONAL PRODUCT MISUSE 119 0.0014
981 INJECTION SITE ERYTHEMA 166 0.0013
982 PSORIASIS 169 0.0013
983 NO ADVERSE EVENT 225 0.0012
984 RHEUMATOID ARTHRITIS 139 0.0012
985 SUICIDE ATTEMPT 70 0.0012
986 PROSTATE CANCER 92 0.0011
987 UNDERDOSE 79 0.0011
988 INJECTION SITE SWELLING 77 0.0010
989 BREAST CANCER 91 0.0010
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 193 0.0010
991 INJECTION SITE BRUISING 75 0.0009
992 COMPLETED SUICIDE 75 0.0009
993 INJECTION SITE PAIN 251 0.0008
994 DRUG WITHDRAWAL SYNDROME 61 0.0007
995 DEVICE ISSUE 62 0.0007